The Prescription Drug User Fee Act: Active postmarketing drug surveillance and safety

Alan Lyles

Research output: Contribution to journal › Editorial › peer-review

ASJC Scopus subject areas

@article{0fb3b76c40a84b5bbb5c19ea9fe1bf8e,

title = "The Prescription Drug User Fee Act: Active postmarketing drug surveillance and safety",

author = "Alan Lyles",

year = "2002",

doi = "10.1016/S0149-2918(02)85153-0",

language = "English (US)",

volume = "24",

pages = "800--802",

journal = "Clinical therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica",

number = "5",

}

TY - JOUR

T1 - The Prescription Drug User Fee Act

T2 - Active postmarketing drug surveillance and safety

AU - Lyles, Alan

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036015030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036015030&partnerID=8YFLogxK

U2 - 10.1016/S0149-2918(02)85153-0

DO - 10.1016/S0149-2918(02)85153-0

M3 - Editorial

C2 - 12075947

AN - SCOPUS:0036015030

SN - 0149-2918

VL - 24

SP - 800

EP - 802

JO - Clinical therapeutics

JF - Clinical therapeutics

IS - 5

ER -